Medicare Enrolled

Dr. Nafiseh Hashemi, MD

Ophthalmology · Encino, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5353 BALBOA BLVD SUIT 110, Encino, CA 91316
8183876565
In practice since 2011 (14 years)
NPI: 1619264645 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hashemi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hashemi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hashemi

Dr. Nafiseh Hashemi is an ophthalmology specialist in Encino, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Hashemi performed 7,338 Medicare services across 2,830 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hashemi received a total of $11,297 from 32 pharmaceutical and/or device companies across 281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hashemi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 13% volume in CA $11,297 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,338
Medicare services
Top 13% in CA for ophthalmology
2,830
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~524 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection (Xeomin), per unit
An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit.
4,100 $4 $20
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
598 $13 $100
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
526 $135 $300
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
353 $34 $100
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
277 $29 $100
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
239 $53 $140
Eye deviation and range of motion exam
An examination to measure eye deviation and assess the range of motion of the eyes.
180 $54 $150
New patient office visit, complex (60-74 min) 163 $173 $400
Extended color vision testing
A comprehensive eye exam that includes specialized tests to evaluate color vision.
142 $49 $150
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
126 $74 $125
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
105 $93 $200
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
102 $30 $150
Incision and drainage of eyelid abscess
A minor surgical procedure to cut open and drain an infected, pus-filled swelling on the eyelid.
94 $298 $783
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
77 $118 $300
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
49 $455 $2,000
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
49 $9 $30
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
39 $281 $500
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
35 $29 $50
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
34 $40 $150
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
30 $190 $500
Eye photography
Photographic imaging of the interior structures of the eye.
20 $17 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
65.6% medium
33.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,297
Total received (2018-2024)
Avg $1,614/year across 7 years
Top 13% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
281
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,278 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,862
2023
$1,540
2022
$1,255
2021
$1,104
2020
$640
2019
$1,995
2018
$1,902

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,128
Alcon Vision LLC
$538
Alexion Pharmaceuticals, Inc.
$376
SUN PHARMACEUTICAL INDUSTRIES INC.
$219
Bausch & Lomb Americas Inc.
$192
Dompe US, Inc.
$149
Merz Pharmaceuticals, LLC
$131
Tarsus Pharmaceuticals, Inc.
$70
Oyster Point Pharma, Inc.
$33
PFIZER INC.
$27
Top 3 companies account for 71.3% of 2024 payments
All-time payments by company (2018-2024) ›
Johnson & Johnson Surgical Vision, Inc.
$1,635
Horizon Therapeutics plc
$1,272
Amgen Inc.
$1,128
Alexion Pharmaceuticals, Inc.
$891
Alcon Laboratories Inc
$824
Bausch & Lomb Americas Inc.
$645
Alcon Vision LLC
$628
Merz Pharmaceuticals, LLC
$453
Bausch & Lomb, a division of Bausch Health US, LLC
$430
Aerie Pharmaceuticals, Inc.
$415
Merz North America, Inc.
$403
Novartis Pharmaceuticals Corporation
$274
SUN PHARMACEUTICAL INDUSTRIES INC.
$262
Allergan, Inc.
$247
Dompe US, Inc.
$210
Shire North American Group Inc
$208
Sun Pharmaceutical Industries Inc.
$169
Akorn Operating Company LLC
$150
Kala Pharmaceuticals, Inc.
$143
Biogen, Inc.
$135
GENZYME CORPORATION
$121
EMD Serono, Inc.
$119
Oyster Point Pharma, Inc.
$114
MERZ NORTH AMERICA, INC.
$94
ABBVIE INC.
$74
Tarsus Pharmaceuticals, Inc.
$70
Akorn, Inc.
$44
Carl Zeiss Meditec AG
$39
Mallinckrodt LLC
$33
PFIZER INC.
$27
Thea Pharma Inc.
$22
Travere Therapeutics, Inc.
$19
Top 3 companies account for 35.7% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ACTIVEFOCUS · ARGOS · AcrySof · AzaSite · BESIVANCE · BOTOX · Cequa · Clareon · EYSUVIS · INVELTYS · IYUZEH · LEMTRADA · LOTEMAX SM · LUMIGAN · MIEBO · NURTEC ODT · None Specified · OXERVATE · PAZEO · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · SOLIRIS · Soliris · TEPEZZA · TYRVAYA · TYSABRI · Tecnis 1-piece IOL · ULTOMIRIS · UPLIZNA · VUITY · VYZULTA · XDEMVY · XEOMIN · XIIDRA · Xeomin · Zioptan · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Encino?
Compare ophthalmologists in the Encino area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
629
Per 100K population
6.4
County median income
$87,760
Nearest hospital
ENCINO HOSPITAL MEDICAL CENTER
1.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hashemi is a mixed practice specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 13% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hashemi experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Hashemi performed 4,100 botox injection (xeomin), per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hashemi receive payments from pharmaceutical companies?
Yes. Dr. Hashemi received a total of $11,297 from 32 companies across 281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hashemi's costs compare to other ophthalmologists in Encino?
Dr. Hashemi's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hashemi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →